Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,284.00
Bid: 2,035.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 253.00 (12.432%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,284.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2022 AGM – Voting Results Update Statement

12 Jan 2023 07:00

RNS Number : 4597M
Halma PLC
12 January 2023
 

Halma plc ('Halma')

 

2022 Annual General Meeting - Voting Results Update Statement

At the Company's Annual General Meeting ("AGM") held on 21 July 2022, the total votes received in favour of Resolution 3 (Remuneration Report) was 67.14%. The total votes received in favour of Resolution 10 (the re-election of Jo Harlow, as a director) was 76.78%, and we understand from shareholders that this was linked to her role as Remuneration Committee Chair.

Given more than 20 per cent of votes were cast against these Resolutions, the Company is providing an update on the views received from shareholders and actions taken as set out under the provisions of the UK Corporate Governance Code.

Since the AGM, we have completed a thorough shareholder engagement, outlining Halma's continuing strong profit and valuation growth over the past twenty years, as well as clarifying that retention risk was part of the rationale for the variable pay and salary reset implemented over two years, in 2021 and 2022. 

 

The benefits of this reset were demonstrated during the period. As part of a well-planned CEO transition process over the past 12 months, Halma was able to successfully recruit an experienced FTSE 100 Group CFO, Steve Gunning, to replace Marc Ronchetti, who will be promoted to the Group CEO with effect from 1 April 2023. No further future changes were raised or requested by the shareholders with whom we met.

 

The Board would like to thank all the shareholders that have taken part in the engagement and for the feedback provided. In line with our normal practice, the Board will continue to engage with shareholders and their representative bodies and will provide a final update in the 2023 Directors' Remuneration Report.

For further information, please contact:

Mark Jenkins

Company Secretary, Halma plc

Tel: +44 (0)1494 721111

 

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad market areas where it operates:

· Safety - Protecting people's safety and the environment as populations grow, and enhancing worker safety

· Environment - Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research 

· Health - Meeting the increasing demand for better healthcare as chronic illness rises, driving by growing and ageing populations and lifestyle changes.

It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUAORROKUAAUR
Date   Source Headline
21st Feb 20227:00 amRNSAcquisition
17th Jan 20227:00 amRNS2021 AGM – Voting Results Update Statement
30th Nov 20211:05 pmRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSAcquisition
18th Nov 20217:00 amRNSHalf Year Results
15th Nov 20217:00 amRNSDirectorate Change
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.